Please try another search
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, Cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, sitagliptin, clopidogrel bisulfate, ticagrelor, rivaroxaban, apixaban, sisapele, esomeprazole, levetiracetam, bovaracetam, sertraline hydrochloride, pramipexole hydrochloride, rivastigmine bitartrate, memantine hydrochloride, and paliperidone. It also provides intermediates; and medical display products, such as diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, and ultrasonic medical displays. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1990 and is headquartered in Xinchang, China.
Name | Age | Since | Title |
---|---|---|---|
Lv Gang | 61 | 2013 | Chairman of the Board |
Chen Meili | 53 | 2013 | VP, CFO & Director |
Wang Nengneng | 50 | 2013 | Vice Chairman |
Tianqing Hu | 59 | - | Chairman of the Supervisory Board |
Jin Zhiping | 42 | 2013 | President & Director |
Fen Juan Lin | 43 | - | Employee Representative Member of the Supervisory Board |
Yunfei Hong | 43 | 2019 | Secretary of the Board & Non-Independent Director |
Hu Wan | - | 2022 | Non-Independent Director |
Zhang Daliang | - | 2022 | Independent Director |
Lei Ying | - | 2022 | Independent Director |
Xiao Jun Xu | 50 | 2019 | Supervisor |
Xu Pan | - | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review